This product contains inactivated influenza A and Adenovirus in storage buffer. The product is to be used for Equipment Verification purposes.

This product contains inactivated inftuenza B and respiratory syncytial virus in storage buffer. The product is to be used as a positive test sample in commercially-available clinical antigen and polymerase chain reaction (PCR) test kits, and in non-commercial clinical laboratory tests for the…

REDx™ SARS-CoV-2 Negative Control is formulated with human fibroblast cells. REDx™ SARS-CoV-2 Negative Control can be utilized as an external sample to monitor the process of SARS-CoV-2 nucleic acid detection assays including extraction and purification, amplification, and detection

This product contains whole genome SARS-CoV-2 B.1.1.7 cDNA and human fibroblast cells desiccated on a swab.

This product consists of swabs containing desiccated SARS-CoV-2 nucleocapsid antigen on Copan FLOQSwabs®.

This product contains cells with Human papiltomavirus type gennomes in a preservative solution. The product is to be used as a positive test sample in polymerase chain reaction (PCR) based tests for HPV-16. The product is to be used for nucleic acid test instrument (device) verification/validation,…

This product contains human fibroblast cells in a preservative solution. The product is to be used as a negative test sample in polymerase chain reaction (PCR) based tests for SARS-CoV-2 detection.

This product contains inactivated TV protozoan parasite in storage buffer. The product is to be used as a positive test sample in nucleic acid based commercially-available clinical test kits, and in non-commercial clinical laboratory tests for the detection of TV protozoa.

This product contains inactivated influenza A virus and influenza B virus in storage buffer. The product is to be used for Equipment Verification purposes.

This product contains inactivated Influenza B virus in storage buffer. The product is to be used as a positive test sample in commercially-available clinical antigen test kits, and in non-commercial clinical laboratory tests for the detection of influenza B antigens. The product is to be used for…

This product contains inactivated HSV 1 virus in storage buffer. The product is to be used as a positive test sample in nucleic acid based commercially-available clinical test kits, and in non-commercial clinical laboratory tests for the detection of HSV 1.

This product contains inactivated influenza A and rotavirus in storage buffer. The product is to be used for immunoassay instrument (device) verification/validation, manufacturing QMS, educational and R&D purposes.

This product contains inactivated Human respiratory syncytia virus (HRSV) in storage buffer.

This product contains inactivated TV protozoan parasite in storage buffer. The product is to be used as a positive test sample in nucleic acid based commercially-available clinical test kits, and in non-commercial clinical laboratory tests for the detection of TV protozoa.

This product contains three SARS-CoV-2 wild type swabs, three of each SARS-CoV-2 Variants of Concern (VOC) : B.1.1.7 , B.1.351 and P1 type swabs all the are containing desiccated formulation of whole SARS CoV-2 cDNA genome and human fibroblasts.

The product contains inactivated HSV 2 virus in storage buffer.

This product contains three SARS-CoV-2 wild type swabs, three of each SARS-CoV-2 Variants of Concern (VOC) : B.1.1.7 , B.1.351 and P1 type swabs all the are containing desiccated formulation of whole SARS CoV-2 cDNA genome and human fibroblasts.

This product contains whole genome SARS-CoV-2 P.1 cDNA and human fibroblast cells desiccated on a swab

This product contains inactivated Crypto in storage buffer. The product is to be used as a positive test sample in commercially-available clinical antigen test kits, and in non-commercial clinical laboratory tests for the detection of Cryptosporidium antigens. The product is to be used for…

REDx™ FLOQ® Respiratory Swab Negative Control can be utilized as an external sample to monitor the process of respiratory pathogen diagnostic assays

This product contains inactivated Chlamydia trachomatis in storage buffer. The product is to be used for Equipment Verification purposes.

The product kit consists of the following: PROCEEDx™FLOQ® SARS-CoV-2 B.1.1.7 Positive swab x 3 PROCEEDx™FLOQ® SARS-CoV-2 B.1.351 Positive swab x 3 PROCEEDx™FLOQ® SARS-CoV-2 P.1 Positive swab x 3 PROCEEDx™FLOQ® SARS-CoV-2 B.1.617 Positive Swab x 3 …

This product contains inactivated respiratory syncytial virus and rotavirus in storage buffer. The product is to be used for Equipment Verification purposes.

This product contains eight Positive swabs, four negative swabs containing desiccated human fibroblast cells and eight positive swabs containing desiccated formulation of whole SARS-CoV-2 cDNA genome and human fibroblasts.

This product contains dry preparation of inactivated influenza B virus on a swab. The product is to be used for Equipment Verification purposes.

This product contains inactivated influenza B and rotavirus in storage buffer. The product is to be used as a positive test sample in commercially-available clinical antigen test kits, and in non-commercial clinical laboratory tests for the detection of influenza B and rotavirus antigens.

This product contains inactivated Chlamydia trachomatis. Neisseria gonorrhoeae and human DNA in a preservative solution. The product is to be used as a positive test sample in potymerase chain reaction (PCR) based tests for C. trachomatis and/or N. gonorrhoeae.

This product contains dry preparation of inactivated Influenza B virus on a swab. The product is to be used for Verification\Validation purposes.

The product is to be used for Verification\Validation purposes.

This product contains inactivated Giardia in storage buffer.The product is to be used as a positive test sample in commercially-available clinical antigen test kits, and in non-commercial clinical laboratory tests for the detection of Giardia antigens. The product is to be used for immunodiagnostic…

This product contains eight Positive swabs, four negative swabs containing desiccated human fibroblast cells and eight positive swabs containing desiccated formulation of whole SARS-CoV-2 cDNA genome and human fibroblasts.

REDx™ Mycoplasma genitalium Positive Control is formulated with whole inactivated bacterial and human fibroblast cells. REDx™ Mycoplasma genitalium Positive Control can be utilized as an external sample to monitor the process of Mycoplasma genitalium nucleic acid detection assays…